Charles River Laboratories | CRL - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agilent USD 362M 23M 2026-06
Align Technology USD 108.29M 4.48M 2026-06
Bio-Rad Laboratories USD 371.4M 898.5M 2026-06
Bruker USD -62.9M 66.4M 2026-06
Cardinal Health USD 398M 1000K 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Cigna USD 1.66B 6M 2026-06
Concord Medical Services Hldg CNY -65.68M 38.54M 2025-12
CVS Health USD 2.98B 36M 2026-06
Danaher USD 870M 159M 2026-06
Dentsply International USD 37M 47M 2026-06
Elevance Health USD 1.46B 301M 2026-06
Humana USD 694M 492M 2026-06
Illumina USD 207M 73M 2026-06
Incyte USD 585.6M 282.27M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Laboratory Of America USD 298.7M 20.9M 2026-06
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Lonza CHF 426M 119M 2025-06
McKesson USD 614M 1.07B 2026-06
Merck EUR 490M 169M 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
Quest Diagnostics USD 320M 69M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Thermo Fisher Scientific USD 1.74B 85M 2026-06
United Therapeutics USD 333M 58.1M 2026-06
UnitedHealth USD 5.48B 796M 2026-06
Veradigm USD -59.82M 74.35M 2022-12
Waters USD -136M 64M 2026-06
West Pharmaceutical Services USD 154M 15.2M 2026-06